Clinical Trials Directory

Trials / Completed

CompletedNCT03317470

Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators aim to improve adherence to follow-up recommendations for an abnormal Pap and effectively reduce disparities in cervical cancer risk and disease among rural and low-income urban women.

Conditions

Interventions

TypeNameDescription
OTHERBasic needs survey-11 questions about food security, housing personal safety, neighborhood safety, childcare, and transportation
BEHAVIORALLife Navigator* The life navigator will contact women identified with unmet basic needs within two business days of completing the baseline survey. * The life navigator in our study will: (1) identify and assess women's needs; (2) jointly generate solutions to address the needs; (3) develop plans to carry out the solutions, including; (4) help prioritize among multiple needs; (5) identify community resources that could help solve the problem; (6) determine eligibility for services; (7) help women access available resources by scheduling appointments and provide appointment reminders; (8) prepare women to interact with service agencies and/or act as an advocate on their behalf; (9) provide instrumental support such as arranging transportation; (10) actively intervene to resolve barriers to basic needs solutions; (11) oversee follow-up of problem solving actions; and (12) review progress made towards resolving unmet basic needs and adapt solutions accordingly.
OTHERFollow-up survey-5 questions about the acceptability of the basic needs survey
OTHERFollow-up survey (phase II participants only)-7 questions about the effectiveness of the life navigator

Timeline

Start date
2017-08-29
Primary completion
2018-12-09
Completion
2018-12-09
First posted
2017-10-23
Last updated
2019-01-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03317470. Inclusion in this directory is not an endorsement.